{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:14:27Z","timestamp":1790874867079,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.lfs.2020.118136","type":"journal-article","created":{"date-parts":[[2020,7,26]],"date-time":"2020-07-26T01:23:23Z","timestamp":1595726603000},"page":"118136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"C","title":["Epigallocatechin gallate suppresses inflammation in human coronary artery endothelial cells by inhibiting NF-\u03baB"],"prefix":"10.1016","volume":"378","author":[{"given":"Aravind T.","family":"Reddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sowmya P.","family":"Lakshmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Maruthi Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.Ch.","family":"Varadacharyulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmi Devi","family":"Kodidhela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2020.118136_bb0005","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","article-title":"Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"Roth","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2020.118136_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-publhealth-112810-151726","article-title":"Cardiovascular disease: rise, fall, and future prospects","volume":"32","author":"Luepker","year":"2011","journal-title":"Annu. Rev. Public Health"},{"key":"10.1016\/j.lfs.2020.118136_bb0015","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1161\/01.ATV.0000075081.51227.86","article-title":"Genes, environment, and cardiovascular disease","volume":"23","author":"Sing","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.lfs.2020.118136_bb0020","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/1358836X0000500108","article-title":"The endothelium: a new target for therapy","volume":"5","author":"Cooke","year":"2000","journal-title":"Vasc. Med."},{"key":"10.1016\/j.lfs.2020.118136_bb0025","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0033-0620(96)80004-1","article-title":"The cardiac endothelium: functional morphology, development, and physiology","volume":"39","author":"Brutsaert","year":"1996","journal-title":"Prog. Cardiovasc. Dis."},{"key":"10.1016\/j.lfs.2020.118136_bb0030","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1097\/01.ASN.0000132474.50966.DA","article-title":"Endothelial dysfunction","volume":"15","author":"Endemann","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.lfs.2020.118136_bb0035","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nri2171","article-title":"Evolving functions of endothelial cells in inflammation","volume":"7","author":"Pober","year":"2007","journal-title":"Nat. Rev. Immunol"},{"key":"10.1016\/j.lfs.2020.118136_bb0040","series-title":"Seminars in Immunology","first-page":"253","article-title":"Regulation of NF-\u03baB by TNF family cytokines","author":"Hayden","year":"2014"},{"key":"10.1016\/j.lfs.2020.118136_bb0045","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s00395-008-0733-0","article-title":"The role of inflammatory cytokines in endothelial dysfunction","volume":"103","author":"Zhang","year":"2008","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.lfs.2020.118136_bb0050","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1385\/CT:5:2:183","article-title":"NF-kappaB in cardiovascular disease: diverse and specific effects of a \u201cgeneral\u201d transcription factor?","volume":"5","author":"Jones","year":"2005","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.lfs.2020.118136_bb0055","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/1040869059096","article-title":"Dietary polyphenols and the prevention of diseases","volume":"45","author":"Scalbert","year":"2005","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.lfs.2020.118136_bb0060","first-page":"144","article-title":"Diet and cardiovascular diseases","volume":"5","author":"Kromhout","year":"2001","journal-title":"J. Nutr. Health Aging"},{"key":"10.1016\/j.lfs.2020.118136_bb0065","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.2174\/092986708785132979","article-title":"Green tea catechins and cardiovascular health: an update","volume":"15","author":"Babu","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.lfs.2020.118136_bb0070","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jep.2017.08.035","article-title":"Molecular understanding of epigallocatechin gallate (EGCG) in cardiovascular and metabolic diseases","volume":"210","author":"Eng","year":"2018","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.lfs.2020.118136_bb0075","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.bcp.2011.07.093","article-title":"Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications","volume":"82","author":"Singh","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.lfs.2020.118136_bb0080","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.tifs.2019.04.001","article-title":"Trends of tea in cardiovascular health and disease: a critical review","volume":"88","author":"Fang","year":"2019","journal-title":"Trends Food Sci. Technol."},{"key":"10.1016\/j.lfs.2020.118136_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229256","article-title":"Cigarette smoke downregulates Nur77 to exacerbate inflammation in chronic obstructive pulmonary disease (COPD)","volume":"15","author":"Reddy","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2020.118136_bb0090","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2147\/COPD.S230188","article-title":"Glucocorticoid receptor alpha mediates Roflumilast\u2019s ability to restore dexamethasone sensitivity in COPD","volume":"15","author":"Reddy","year":"2020","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"10.1016\/j.lfs.2020.118136_bb0095","first-page":"L758","article-title":"Effects of JAM-A deficiency or blocking antibodies on neutrophil migration and lung injury in a murine model of ALI","volume":"303","author":"Lakshmi","year":"2012","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.lfs.2020.118136_bb0100","first-page":"65","article-title":"Nuclear transcription factor kappa B (NF-\u043aB) and molecular damage mechanisms in acute cardiovascular diseases. A review","volume":"4","author":"Buzas","year":"2018","journal-title":"J. Cardiovasc. Emerg."},{"key":"10.1016\/j.lfs.2020.118136_bb0105","article-title":"NF-kappaB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Sign. Transduct. Target Ther"},{"key":"10.1016\/j.lfs.2020.118136_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molcel.2011.12.023","article-title":"Cysteine 38 holds the key to NF-\u03baB activation","volume":"45","author":"Perkins","year":"2012","journal-title":"Mol. Cell"},{"key":"10.1016\/j.lfs.2020.118136_bb0115","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.2174\/092986709789578222","article-title":"Direct covalent modification as a strategy to inhibit nuclear factor-kappa B","volume":"16","author":"Pande","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.lfs.2020.118136_bb0120","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.freeradbiomed.2008.07.023","article-title":"Covalent modification of proteins by green tea polyphenol (\u2212)-epigallocatechin-3-gallate through autoxidation","volume":"45","author":"Ishii","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.lfs.2020.118136_bb0125","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1021\/acschembio.8b00584","article-title":"Identification and molecular characterization of peroxisome proliferator-activated receptor \u03b4 as a novel target for covalent modification by 15-deoxy-\u039412, 14-prostaglandin J2","volume":"13","author":"Reddy","year":"2018","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.lfs.2020.118136_bb0130","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fimmu.2014.00071","article-title":"Regulation of the NF-kappaB-mediated transcription of inflammatory genes","volume":"5","author":"Bhatt","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2020.118136_bb0135","series-title":"Encyclopedia of Medical Immunology","first-page":"367","article-title":"Endothelial cells and inflammation","author":"Sutton","year":"2014"},{"key":"10.1016\/j.lfs.2020.118136_bb0140","doi-asserted-by":"crossref","first-page":"222","DOI":"10.5830\/CVJA-2011-068","article-title":"Endothelial dysfunction: the early predictor of atherosclerosis","volume":"23","author":"Mudau","year":"2012","journal-title":"Cardiovasc. J. Afr"},{"key":"10.1016\/j.lfs.2020.118136_bb0145","first-page":"183","article-title":"Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome","volume":"1","author":"Hadi","year":"2005","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.lfs.2020.118136_bb0150","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1172\/JCI118598","article-title":"Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion","volume":"97","author":"Brand","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2020.118136_bb0155","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.cmet.2008.08.016","article-title":"Endothelial cell-specific NF-kappaB inhibition protects mice from atherosclerosis","volume":"8","author":"Gareus","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.lfs.2020.118136_bb0160","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1002\/mnfr.201200040","article-title":"Epigallocatechin gallate reduces vascular inflammation in db\/db mice possibly through an NF-kappaB-mediated mechanism","volume":"56","author":"Babu","year":"2012","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.lfs.2020.118136_bb0165","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1423-0127-21-56","article-title":"Molecular identification for epigallocatechin-3-gallate-mediated antioxidant intervention on the H2O2-induced oxidative stress in H9c2 rat cardiomyoblasts","volume":"21","author":"Chen","year":"2014","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.lfs.2020.118136_bb0170","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1159\/000257494","article-title":"Epigallocatechin-3-O-gallate decreases tumor necrosis factor-alpha-induced fractalkine expression in endothelial cells by suppressing NF-kappaB","volume":"24","author":"Lee","year":"2009","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.lfs.2020.118136_bb0175","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1124\/mol.52.3.465","article-title":"(\u2212)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-kappaB","volume":"52","author":"Lin","year":"1997","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.lfs.2020.118136_bb0180","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cbi.2009.09.013","article-title":"Regulatory effect of epigallocatechin gallate on the expression of C-reactive protein and other inflammatory markers in an experimental model of atherosclerosis","volume":"183","author":"Ramesh","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.lfs.2020.118136_bb0185","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.lfs.2013.01.025","article-title":"EGCG attenuates high glucose-induced endothelial cell inflammation by suppression of PKC and NF-kappaB signaling in human umbilical vein endothelial cells","volume":"92","author":"Yang","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2020.118136_bb0190","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1159\/000110446","article-title":"Epigallocatechin-3-O-gallate inhibits the angiotensin II-induced adhesion molecule expression in human umbilical vein endothelial cell via inhibition of MAPK pathways","volume":"20","author":"Chae","year":"2007","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.lfs.2020.118136_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-9-161","article-title":"(\u2212)-Epigallocatechin gallate inhibits endotoxin-induced expression of inflammatory cytokines in human cerebral microvascular endothelial cells","volume":"9","author":"Li","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.lfs.2020.118136_bb0200","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jnutbio.2015.10.003","article-title":"EGCG prevents PCB-126-induced endothelial cell inflammation via epigenetic modifications of NF-\u03baB target genes in human endothelial cells","volume":"28","author":"Liu","year":"2016","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.lfs.2020.118136_bb0205","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/abbs\/gmt128","article-title":"EGCG attenuates pro-inflammatory cytokines and chemokines production in LPS-stimulated L02 hepatocyte","volume":"46","author":"Liu","year":"2014","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.lfs.2020.118136_bb0210","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.bbrc.2004.02.099","article-title":"The tea flavonoid epigallocatechin-3-gallate reduces cytokine-induced VCAM-1 expression and monocyte adhesion to endothelial cells","volume":"316","author":"Ludwig","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2020.118136_bb0215","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1159\/000358702","article-title":"Green tea polyphenol epigallocatechin-3-gallate inhibits TNF-a-induced production of monocyte chemoattractant protein-1 in human umbilical vein endothelial cells","volume":"33","author":"Wang","year":"2014","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.lfs.2020.118136_bb0220","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/mnfr.200500118","article-title":"The role of tea and tea flavonoids in cardiovascular health","volume":"50","author":"Stangl","year":"2006","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.lfs.2020.118136_bb0225","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3945\/ajcn.110.005363","article-title":"Black and green tea consumption and the risk of coronary artery disease: a meta-analysis","volume":"93","author":"Wang","year":"2011","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.lfs.2020.118136_bb0230","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1472-8206.2008.00585.x","article-title":"Epigallocatechin gallate improves serum lipid profile and erythrocyte and cardiac tissue antioxidant parameters in Wistar rats fed an atherogenic diet","volume":"22","author":"Ramesh","year":"2008","journal-title":"Fundam. Clin. Pharmacol"},{"key":"10.1016\/j.lfs.2020.118136_bb0235","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/2049-632X.12001","article-title":"Green tea epigallocatechin-3-gallate attenuates Porphyromonas gingivalis-induced atherosclerosis","volume":"67","author":"Cai","year":"2013","journal-title":"Pathog. Dis"},{"key":"10.1016\/j.lfs.2020.118136_bb0240","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2119\/2004-00032.Aneja","article-title":"Epigallocatechin, a green tea polyphenol, attenuates myocardial ischemia reperfusion injury in rats","volume":"10","author":"Aneja","year":"2004","journal-title":"Mol. Med."},{"key":"10.1016\/j.lfs.2020.118136_bb0245","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.freeradbiomed.2006.01.005","article-title":"Epigallocathechin-3 gallate inhibits cardiac hypertrophy through blocking reactive oxidative species-dependent and -independent signal pathways","volume":"40","author":"Li","year":"2006","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.lfs.2020.118136_bb0250","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.biopha.2007.10.011","article-title":"Protective effect of (\u2212)-epigallocatechin-gallate (EGCG) on lipid peroxide metabolism in isoproterenol induced myocardial infarction in male Wistar rats: a histopathological study","volume":"62","author":"Devika","year":"2008","journal-title":"Biomed. Pharmacother"},{"key":"10.1016\/j.lfs.2020.118136_bb0255","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.redox.2013.12.022","article-title":"New insights into the mechanisms of polyphenols beyond antioxidant properties; lessons from the green tea polyphenol, epigallocatechin 3-gallate","volume":"2","author":"Kim","year":"2014","journal-title":"Redox Biol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520308870?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520308870?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T11:19:21Z","timestamp":1751195961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320520308870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":51,"alternative-id":["S0024320520308870"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118136","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigallocatechin gallate suppresses inflammation in human coronary artery endothelial cells by inhibiting NF-\u03baB","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118136","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"118136"}}